Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Lee Henderson, PhD
CEO, VYBION, INC
Vybion, Inc
Monterey, California, United States
Dave Hering
CEO, INVIVYD
New Tools in the Infectious Disease Toolbox: Combatting Future Biological Threats
Burlington, Vermont, United States
Terry Hermiston, PhD
CEO, COAGULANT THERAPEUTICS CORPORATION
Coagulant Therapeutics Corporation
Berkeley, California, United States
Volker Herrmann
PRESIDENT AND CEO, SONATA THERAPEUTICS
Are We Past the Checkpoint?
Watertown, Massachusetts, United States
Matthew Hewitt, PhD,BA
VICE PRESIDENT, TECHNICAL OFFICER CGT & BIOLOGICS, CHARLES RIVER LABORATORIES
Benefits and Limitations of De-Centralizing Cell Therapy Manufacturing and Clinical Development
Wilmington, MA 01887, Massachusetts, United States
Matthew Hill, PhD
CEO, ELEGEN CORP.
Making the Dream of Synthetic Biology a Reality
Belmont, California, United States
Placeholder Photo
Elizabeth Hillebrenner
ASSOCIATE DIRECTOR FOR SCIENTIFIC AND REGULATORY PROGRAMS, FDA, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
In Vitro Diagnostics Regulation in the US and Beyond: Trends and Strategies to Navigate Change
Kate Hillier, JD
PARTNER, COOLEY LLP
Navigating Partnering in a Down Market: Finding Post-Pandemic Opportunity
Seattle, Washington, United States
Art Hirt
SVP, VACCINES BUSINESS UNIT, MERCK
The Time is Now: Turning up the Dial on Adult Immunization Across the Globe
Michael Hodin, PhD
CEO; MANAGING PARTNER, GLOBAL COALITION ON AGING; HIGH LANTERN GROUP
The Time is Now: Turning up the Dial on Adult Immunization Across the Globe